<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04110262</url>
  </required_header>
  <id_info>
    <org_study_id>HL140488</org_study_id>
    <nct_id>NCT04110262</nct_id>
  </id_info>
  <brief_title>Human Sodium Balance Study</brief_title>
  <acronym>MEASURE</acronym>
  <official_title>Sodium Regulation in Individuals on Known Dietary Sodium Intake</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to examine how dietary sodium is used by the body. In
      a racially diverse sample of adults, the investigators will examine the effects of high and
      low dietary sodium intake on the storage and excretion of sodium and determine whether sodium
      distribution affects blood pressure. This has implications for how investigators interpret
      studies that use urine biomarkers of sodium. Study findings about tissue sodium storage also
      have implications for managing hypertension and related conditions.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Dietary intervention consisting of two 25-day feeding periods separated by a 10-day washout.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Throughout data collection, study data collectors and the study coordinator will remain blinded to participants' exposure group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated sodium concentration in skin and muscle</measure>
    <time_frame>60 days</time_frame>
    <description>The concentration of sodium in skin and muscle will be measured, and the difference in concentrations resulting from high versus low sodium intakes will be calculated. Skin and muscle sodium stores will be non-invasively quantified using 23sodium-magnetic resonance imaging (23Na-MRI).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated sodium concentration in bone</measure>
    <time_frame>60 days</time_frame>
    <description>The concentration of sodium in bone will be measured, and the difference in concentrations resulting from high versus low sodium intakes will be calculated. Sodium storage in bone will be measured non-invasively using in vivo neutron activation analysis (IVNAA) technology to quantify the concentration of Na in the hand.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of sodium, potassium, and hormone regulators in excreted urine</measure>
    <time_frame>60 days</time_frame>
    <description>Urinary concentration of sodium, potassium, and hormones (renin, angiotensin, aldosterone, free cortisol, free cortisone, glucocorticoid, and mineralocorticoid) will be measured and variation over time will be calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>60 days</time_frame>
    <description>Blood pressure under high versus low dietary sodium conditions will be measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Racial differences in concentrations of sodium in skin, muscle and bone</measure>
    <time_frame>60 days</time_frame>
    <description>Blacks/African Americans mean sodium concentrations versus the average of the means of each of the other racial/ethnic groups will be examined.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Racial differences in concentration of urinary potassium excretion</measure>
    <time_frame>60 days</time_frame>
    <description>The concentration of potassium excreted in urine will be compared between Blacks/African Americans versus the pooled sample of other racial/ethnic groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>High-low dietary sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High sodium diet (3400 mg/day) feeding period followed by low sodium diet (2300 mg/day) feeding period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-high dietary sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low sodium diet (2300 mg/day) feeding period followed by high sodium diet (3400 mg/day) feeding period</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High dietary sodium intake</intervention_name>
    <description>Twenty five day feeding period of high dietary sodium (3400 mg/day)</description>
    <arm_group_label>High-low dietary sodium</arm_group_label>
    <arm_group_label>Low-high dietary sodium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low dietary sodium intake</intervention_name>
    <description>Twenty five day feeding period of low dietary sodium (2300 mg/day)</description>
    <arm_group_label>High-low dietary sodium</arm_group_label>
    <arm_group_label>Low-high dietary sodium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-69 years old;

          -  Diagnosed with high blood pressure;

          -  Taking no more than one medication for high blood pressure;

          -  Currently has a primary care provider;

          -  Willing to eat all meals provided by the study for a total of 50 days.

        Exclusion Criteria:

          -  Diabetes;

          -  Smoker;

          -  Serious food allergies;

          -  Currently pregnant or planning to become pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cheryl A Anderson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cheryl A Anderson, PhD</last_name>
    <phone>858-534-4456</phone>
    <email>c1anderson@ucsd.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Valerie Mercer, MPH, MA</last_name>
    <phone>858-246-5560</phone>
    <email>vjmercer@ucsd.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Cheryl A Anderson, PhD</last_name>
      <phone>858-534-4456</phone>
      <email>c1anderson@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Cheryl A Anderson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natalie Sweiss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>June 19, 2020</last_update_submitted>
  <last_update_submitted_qc>June 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Cheryl Anderson</investigator_full_name>
    <investigator_title>Professor / Interim Chair</investigator_title>
  </responsible_party>
  <keyword>Blood pressure</keyword>
  <keyword>Sodium</keyword>
  <keyword>Salt</keyword>
  <keyword>Randomized controlled trial</keyword>
  <keyword>balance</keyword>
  <keyword>humans</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

